Evaluation of safety and efficacy of erlotinib as monotherapy for Chinese patients with advanced non-small cell lung cancer

被引：0
|
作者：
Zhang, Xiao-Tong [1 ]
Li, Long-Yun [1 ]
Wang, Meng-Zhao [1 ]
Zhang, Li [1 ]
Zhong, Wei [1 ]
Wang, Shu-Lan [1 ]
机构：
[1] Beijing Union Med Coll Hosp, Beijing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：184 / 185
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of anlotinib in patients with advanced non-small cell lung cancer
    Zhong, Yuejiao
    Wei, Qiang
    Lu, You
    Tang, Xiuliang
    Wang, Zhongqiu
    Chen, Lingxiang
    JOURNAL OF THORACIC DISEASE, 2020, 12 (10) : 6016 - 6022
  • [22] Efficacy of erlotinib and celecoxib for patients with advanced non-small cell lung cancer: A retrospective study
    Jin, Yi-Hua
    Li, Wei-Hong
    Bai, Yan
    Ni, Lei
    MEDICINE, 2019, 98 (10)
  • [23] ERLOTINIB FOR ADVANCED NON-SMALL CELL LUNG CANCER: EVALUATION IN SINGLE INSTITUTE
    Kayatani, H.
    Fujiwara, K.
    Tokimasa, Y.
    Higo, H.
    Kameyama, N.
    Matsushita, M.
    Matsuo, K.
    Yonei, T.
    Sato, T.
    RESPIROLOGY, 2011, 16 : 164 - 164
  • [24] Genetic Association of Drug Response to Erlotinib in Chinese Advanced Non-small Cell Lung Cancer Patients
    Wang, Cong
    Chen, Fang
    Liu, Yichen
    Xu, Qingqing
    Guo, Liang
    Zhang, Xiaoqing
    Ruan, Yunfeng
    Shi, Ye
    Shen, Lu
    Li, Mo
    Du, Huihui
    Sun, Xiaofang
    Ma, Jingsong
    He, Lin
    Qin, Shengying
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [25] Efficacy of erlotinib in previously treated patients with advanced non-small cell lung cancer: analysis of the Chinese subpopulation in the TRUST study
    Huang, Yisheng
    Zhang, Li
    Shi, Yuankai
    Ma, Shenglin
    Liao, Meilin
    Bai, Chunxue
    Zhang, Qingyuan
    Wang, Changli
    Luo, Feng
    Yu, Shiying
    Qin, Shukui
    Zhi, Xiuyi
    Zhou, Caicun
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (06) : 569 - 575
  • [26] Comparing Efficacy of Erlotinib and Bevacizumab Combination with Erlotinib Monotherapy in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis
    Sakharkar, Prashant
    Kurup, Sonali
    DISEASES, 2023, 11 (04)
  • [27] Efficacy and safety of icotinib in Chinese patients with advanced non-small cell lung cancer after failure of chemotherapy
    Lan, Shao
    Zhang Beibei
    He Chunxiao
    Lin Baochai
    Song Zhengbo
    Lou Guangyuan
    Yu Xinmin
    Zhang Yiping
    CHINESE MEDICAL JOURNAL, 2014, 127 (02) : 266 - 271
  • [28] Efficacy and Safety of Pralsetinib in Chinese Patients with Advanced RET Fusion plus Non-Small Cell Lung Cancer
    Zhou, Q.
    Wu, Y.
    Chang, J.
    Wang, H.
    Fan, Y.
    Zhao, J.
    Wu, G.
    Sun, Y.
    Sun, M.
    Wang, X.
    Shi, H.
    Nian, W.
    Wang, K.
    Zheng, X.
    Qu, L.
    Yao, S.
    Shen, Z.
    Li, P.
    Yang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S889 - S890
  • [29] Safety profile of erlotinib in patients with advanced non-small cell lung cancer with chronic renal failure
    Gridelli, Cesare
    Maione, Paolo
    Galetta, Domenico
    Rossi, Antonio
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (01) : 96 - 98
  • [30] Efficacy and Safety of Erlotinib in 1242 East/South-East Asian Patients with Advanced Non-small Cell Lung Cancer
    Mok, Tony
    Wu, Yi-long
    Au, Joseph Siu-kie
    Zhou, Caicun
    Zhang, Li
    Perng, Reury-Perng
    Park, Keunchil
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (10) : 1609 - 1615
12345